BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 19199193)

  • 1. Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumonia.
    Eagye KJ; Nicolau DP; Kuti JL
    Semin Respir Crit Care Med; 2009 Feb; 30(1):116-23. PubMed ID: 19199193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia.
    Nicasio AM; Eagye KJ; Kuti EL; Nicolau DP; Kuti JL
    Pharmacotherapy; 2010 May; 30(5):453-62. PubMed ID: 20411997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia.
    Shorr AF; Tabak YP; Gupta V; Johannes RS; Liu LZ; Kollef MH
    Crit Care; 2006; 10(3):R97. PubMed ID: 16808853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.
    Shorr AF; Combes A; Kollef MH; Chastre J
    Crit Care Med; 2006 Mar; 34(3):700-6. PubMed ID: 16505656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia.
    Agbaht K; Diaz E; Muñoz E; Lisboa T; Gomez F; Depuydt PO; Blot SI; Rello J
    Crit Care Med; 2007 Sep; 35(9):2064-70. PubMed ID: 17581489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.
    Warren DK; Shukla SJ; Olsen MA; Kollef MH; Hollenbeak CS; Cox MJ; Cohen MM; Fraser VJ
    Crit Care Med; 2003 May; 31(5):1312-7. PubMed ID: 12771596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for relapse of ventilator-associated pneumonia related to nonfermenting Gram negative bacilli: a case-control study.
    Nseir S; Deplanque X; Di Pompeo C; Diarra M; Roussel-Delvallez M; Durocher A
    J Infect; 2008 May; 56(5):319-25. PubMed ID: 18405975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of ventilator-associated pneumonia on the Canadian health care system.
    Muscedere JG; Martin CM; Heyland DK
    J Crit Care; 2008 Mar; 23(1):5-10. PubMed ID: 18359415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infections in a surgical intensive care unit of a university hospital in Greece.
    Markogiannakis H; Pachylaki N; Samara E; Kalderi M; Minettou M; Toutouza M; Toutouzas KG; Theodorou D; Katsaragakis S
    Int J Infect Dis; 2009 Mar; 13(2):145-53. PubMed ID: 18775663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.
    Lorente L; Jiménez A; Palmero S; Jiménez JJ; Iribarren JL; Santana M; Martín MM; Mora ML
    Clin Ther; 2007 Nov; 29(11):2433-9. PubMed ID: 18158083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does bronchoalveolar lavage enhance our ability to treat ventilator-associated pneumonia in a trauma-burn intensive care unit?
    Wahl WL; Franklin GA; Brandt MM; Sturm L; Ahrns KS; Hemmila MR; Arbabi S
    J Trauma; 2003 Apr; 54(4):633-8; discussion 638-9. PubMed ID: 12707523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia.
    Combes A; Luyt CE; Fagon JY; Wolff M; Trouillet JL; Chastre J
    Crit Care Med; 2007 Jan; 35(1):146-54. PubMed ID: 17080004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a hospital-acquired/ventilator-associated/healthcare-associated pneumonia practice guideline on outcomes in surgical trauma patients.
    Worrall CL; Anger BP; Simpson KN; Leon SM
    J Trauma; 2010 Feb; 68(2):382-6. PubMed ID: 19935109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inadequate treatment of ventilator-associated pneumonia: risk factors and impact on outcomes.
    Teixeira PJ; Seligman R; Hertz FT; Cruz DB; Fachel JM
    J Hosp Infect; 2007 Apr; 65(4):361-7. PubMed ID: 17350721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy.
    Garnacho-Montero J; Sa-Borges M; Sole-Violan J; Barcenilla F; Escoresca-Ortega A; Ochoa M; Cayuela A; Rello J
    Crit Care Med; 2007 Aug; 35(8):1888-95. PubMed ID: 17581492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in early- and late-onset ventilator-associated pneumonia between surgical and trauma patients in a combined surgical or trauma intensive care unit.
    Hedrick TL; Smith RL; McElearney ST; Evans HL; Smith PW; Pruett TL; Young JS; Sawyer RG
    J Trauma; 2008 Mar; 64(3):714-20. PubMed ID: 18332812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
    Arnold HM; Sawyer AM; Kollef MH
    Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of APACHE II, SOFA and CPIS scores in predicting prognosis in patients with ventilator-associated pneumonia.
    Gursel G; Demirtas S
    Respiration; 2006; 73(4):503-8. PubMed ID: 16205047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study.
    Korbila IP; Michalopoulos A; Rafailidis PI; Nikita D; Samonis G; Falagas ME
    Clin Microbiol Infect; 2010 Aug; 16(8):1230-6. PubMed ID: 19732088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.